Innate IgM antibodies to mannose in patients with gastric cancer  

作　　者：Maxim Petrovich Nikulin Nadezhda Vladimirovna Shilova Alexander Dmitrievich Lipatnikov Ivan Sokratovich Stilidi Alexandra Vladimirovna Semyanikhina Nikolai Vladimirovich Bovin Nikolai Nikolaevich Tupitsyn 

机构地区：[1]Federal State Budgetary Institution"National Medical Research Center for Oncology Named After N.N.Blokhin"of the Ministry of Health of Russia,Moscow,Russia [2]State Research Center"Institute of Bioorganic Chemistry Named After Academicians M.M.Shemyakin and Yu.A.Ovchinnikov"of the Russian Academy of Sciences,Moscow,Russia [3]National Medical Research Center for Obstetrics,Gynecology and Perinatology Named After Academician VI.Kulakov of the Ministry of Health of Russian Federation,Moscow,Russia

出　　处：《Cancer Biology & Medicine》2024年第3期193-197,共5页癌症生物学与医学（英文版）

基　　金：supported by the Russian Science Foundation (Grant No. 22-24-00398)。

摘　　要：Gastric cancer(GC) remains one of the most common lethal diseases. Every year, about 1 million people fall ill and almost 800 thousand people die worldwide~1. Surgical treatment has reached its limit. The current advances in immunology and detection of epidermal growth factor molecules(EGFR) in gastric cancer cells allowed to improve the treatment results;however, the metastatic form of this disease is still incurable.

关 键 词：GASTRIC cancer GASTRIC 

分 类 号：R735.2[医药卫生—肿瘤]